|
1
|
Stathis A and Moore MJ: Advanced
pancreatic carcinoma: Current treatment and future challenges. Nat
Rev Clin Oncol. 7:163–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ilic M and Ilic I: Epidemiology of
pancreatic cancer. World J Gastroenterol. 22:9694–9705. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Feig C, Gopinathan A, Neesse A, Chan DS,
Cook N and Tuveson DA: The pancreas histological characteristics.
Clin Cancer Res. 18:4266–4276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kobayashi H, Enomoto A, Woods SL, Burt AD,
Takahashi M and Worthley DL: Cancer-associated fibroblasts in
gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 16:282–295.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Neesse A, Bauer CA, Öhlund D, Lauth M,
Buchholz M, Michl P, Tuveson DA and Gress TM: Stromal biology and
therapy in pancreatic cancer: Ready for clinical translation? Gut.
68:159–171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Öhlund D, Elyada E and Tuveson D:
Fibroblast heterogeneity in the cancer wound. J Exp Med.
211:1503–1523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gieniec KA, Butler LM, Worthley DL and
Woods SL: Cancer-associated fibroblasts-heroes or villains? Br J
Cancer. 121:293–302. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ishii G, Ochiai A and Neri S: Phenotypic
and functional heterogeneity of cancer-associated fibroblast within
the tumor microenvironment. Adv Drug Deliv Rev. 99:186–196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mezawa Y and Orimo A: The roles of tumor-
and metastasis-promoting carcinoma-associated fibroblasts in human
carcinomas. Cell Tissue Res. 365:675–689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
El Khouli RH, Macura KJ, Kamel IR, Jacobs
MA and Bluemke DA: 3-T dynamic contrast-enhanced MRI of the breast:
Pharmacokinetic parameters versus conventional kinetic curve
analysis. AJR Am J Roentgenol. 197:1498–1505. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang SN, Li FJ, Chen JM, Zhang G, Liao YH
and Huang TC: Kinetic curve type assessment for classification of
breast lesions using dynamic contrast-enhanced MR imaging. PLoS
One. 11:e01528272016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jabbar SB, Lynch B, Seiler S, Hwang H and
Sahoo S: Pathologic findings of breast lesions detected on magnetic
resonance imaging. Arch Pathol Lab Med. 141:1513–1522. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hattori Y, Gabata T, Matsui O, Mochizuki
K, Kitagawa H, Kayahara M, Ohta T and Nakanuma Y: Enhancement
patterns of pancreatic adenocarcinoma on conventional dynamic
multi-detector row CT: Correlation with angiogenesis and fibrosis.
World J Gastroenterol. 15:3114–3121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brierley JD, Gospodarowicz MK and
Wittekind C: The TNM classification of malignant tumours, 8th
edition. Wiley Blackwell; Oxford: pp. 93–95. 2017
|
|
17
|
WHO Classification of Tumours Editorial
Board. WHO classification of tumours of the digestive system. IARC
Press; Lyon: pp. 322–332. 2019
|
|
18
|
Inoue C, Miki Y, Saito R, Hata S, Abe J,
Sato I, Okada Y and Sasano H: PD-L1 induction by cancer-associated
fibroblast-derived factors in lung adenocarcinoma cells. Cancers
(Basel). 11:12572019. View Article : Google Scholar
|
|
19
|
Itou RA, Uyama N, Hirota S, Kawada N, Wu
S, Miyashita S, Nakamura I, Suzumura K, Sueoka H, Okada T, et al:
Immunohistochemical characterization of cancer-associated
fibroblasts at the primary sites and in the metastatic lymph nodes
of human intrahepatic cholangiocarcinoma. Hum Pathol. 83:77–89.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Li S, Zhao Y, Ma P, Cao Y, Liu C,
Zhang X, Wang W, Chen L and Li Y: Cancer-associated fibroblasts
promote the migration and invasion of gastric cancer cells via
activating IL-17a/JAK2/STAT3 signaling. Ann Transl Med. 8:8772020.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amornsupak K, Jamjuntra P, Warnnissorn M,
O-Charoenrat P, Sa-Nguanraksa D, Thuwajit P, Eccles SA and Thuwajit
C: High ASMA+ fibroblasts and low cytoplasmic
HMGB1+ breast cancer cells predict poor prognosis. Clin
Breast Cancer. 17:441–452.e2. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsuda K, Ohga N, Hida Y, Muraki C,
Tsuchiya K, Kurosu T, Akino T, Shih SC, Totsuka Y, Klagsbrun M, et
al: Isolated tumor endothelial cells maintain specific character
during long-term culture. Biochem Biophys Res Commun. 394:947–954.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yi CA, Lee KS, Kim EA, Han J, Kim H, Kwon
OJ, Jeong YJ and Kim S: Solitary pulmonary nodules: Dynamic
enhanced multi-detector row CT study and comparison with vascular
endothelial growth factor and microvessel density. Radiology.
233:191–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang JH, Min PQ, Wang PJ, Cheng WX, Zhang
XH, Wang Y, Zhao XH and Mao XQ: Dynamic CT evaluation of tumor
vascularity in renal cell carcinoma. AJR Am J Roentgenol.
186:1423–1430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
El-Gohary YM, Metwally G, Saad RS,
Robinson MJ, Mesko T and Poppiti RJ: Prognostic significance of
intratumoral and peritumoral lymphatic density and blood vessel
density in invasive breast carcinomas. Am J Clin Pathol.
129:578–586. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nieto Y, Woods J, Nawaz F, Baron A, Jones
RB, Shpall EJ and Nawaz S: Prognostic analysis of tumour
angiogenesis, determined by microvessel density and expression of
vascular endothelial growth factor, in high-risk primary breast
cancer patients treated with high-dose chemotherapy. Br J Cancer.
97:391–397. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Macchiarini P, Fontanini G, Hardin MJ,
Squartini F and Angeletti CA: Relation of neovascularisation to
metastasis of nonsmall-cell lung cancer. Lancet. 340:145–146. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fontanini G, Lucchi M, Vignati S, Mussi A,
Ciardiello F, De Laurentiis M, De Placido S, Basolo F, Angeletti CA
and Bevilacqua G: Angiogenesis as a prognostic indicator of
survival in non-small-cell lung carcinoma: A prospective study. J
Natl Cancer Inst. 89:881–886. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vermeulen PB, Van den Eynden GG, Huget P,
Goovaerts G, Weyler J, Lardon F, Van Marck E, Hubens G and Dirix
LY: Prospective study of intratumoral microvessel density, p53
expression and survival in colorectal cancer. Br J Cancer.
79:316–322. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Katsuta E, Qi Q, Peng X, Hochwald SN, Yan
L and Takabe K: Pancreatic adenocarcinomas with mature blood
vessels have better overall survival. Sci Rep. 9:13102019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Awai K and Date S: Basic knowledge to
achieve optimal enhancement of CT. Nichidoku Iho. 56:13–32.
2011.
|
|
33
|
Tsujino T, Seshimo I, Yamamoto H, Ngan CY,
Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N and Monden M:
Stromal myofibroblasts predict disease recurrence for colorectal
cancer. Clin Cancer Res. 13:2082–2090. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang LM, Silva MA, D'Costa Z, Bockelmann
R, Soonawalla Z, Liu S, O'Neill E, Mukherjee S, McKenna WG, Muschel
R and Fokas E: The prognostic role of desmoplastic stroma in
pancreatic ductal adenocarcinoma. Oncotarget. 7:4183–4194. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miyai Y, Esaki N, Takahashi M and Enomoto
A: Cancer-associated fibroblasts that restrain cancer progression:
Hypotheses and perspectives. Cancer Sci. 111:1047–1057. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alcaraz J, Carrasco JL, Millares L, Luis
IC, Fernández-Porras FJ, Martínez-Romero A, Diaz-Valdivia N, De Cos
JS, Rami-Porta R, Seijo L, et al: Stromal markers of activated
tumor associated fibroblasts predict poor survival and are
associated with necrosis in non-small cell lung cancer. Lung
Cancer. 135:151–160. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mizutani Y, Kobayashi H, Iida T, Asai N,
Masamune A, Hara A, Esaki N, Ushida K, Mii S, Shiraki Y, et al:
Meflin-positive cancer-associated fibroblasts inhibit pancreatic
carcinogenesis. Cancer Res. 79:5367–5381. 2019. View Article : Google Scholar : PubMed/NCBI
|
